CVS HEALTH Corp — Director's Dealing 2021

Apr 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-02-01

Reporting Person: Moriarty Thomas M (EVP & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-01	Common Stock	A	124048	—	Acquired	124048	Direct
2021-04-01	Common Stock	F	61095	$74.30	Disposed	62953	Direct
2021-04-01	Common Stock	F	2350	$74.30	Disposed	65373	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-01	Stock Option	$74.30	A	155495	Acquired	2031-04-01	Common Stock (155495)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	18226.0221	Indirect
Common Stock (restricted)	8008	Direct
Stock Unit	45455.2448	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$102.26	2022-04-01	Common Stock (51361)	51361	Direct
Stock Option	$104.82	2023-04-01	Common Stock (71696)	71696	Direct
Stock Option	$78.05	2024-04-03	Common Stock (125224)	125224	Direct
Stock Option	$62.21	2025-04-01	Common Stock (145959)	145959	Direct
Stock Option	$54.19	2029-04-01	Common Stock (202007)	202007	Direct
Stock Option	$58.34	2030-04-01	Common Stock (197116)	197116	Direct

Footnotes

F1: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

F2: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

F3: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.

F4: Option becomes exercisable in four equal installments, commencing 4/1/2022.

F5: Option became exercisable in four equal annual installments, commencing 4/1/2016.

F6: Option became exercisable in four equal annual installments, commencing 4/1/2017.

F7: Option became exercisable in four equal annual installments, commencing 4/3/2018.

F8: Option became exercisable in four equal annual installments, commencing 4/1/2019.

F9: Option became exercisable in four equal annual installments, commencing 4/1/2020.

F10: The number of shares subject to the option were calculated using a 30-day average price.

F11: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.